Introduction
Controlling MRSA has been a challenge for Geneva University Hospitals (HUG), particularly after the introduction of ST228 SCCmecI hyperendemic clone in 1999.
Objectives
To describe HUG's secular trends of MRSA, infection control measures and predominant MRSA clones using Staphylococcal chromosomic cassettes (SCCmec) genotyping.
Methods
A multifaceted MRSA prevention program initiated in 1993 included patient screening, decontamination, surveillance, contact isolation, an alert system and a hospitalwide hand hygiene campaign (HHC); subsequently strengthened by: an educational campaign (2003), routine MRSA SCCmec genotyping (2005), a 2 nd HHC, periodic audits and feedback (2006) . The intensive care unit performed MRSA screening on admission, discharge and weekly since 2004. Surveillance included: (1) incidence rates (IR) of hospital acquired (HA)-MRSA infection or colonization; (2) HA-MRSA bloodstream infections (BSI);
(3) proportion of MRSA/S. aureus BSI; (4) IR of MRSA clinical cultures (CC); (5) proportion of SCCmec in MRSA strains, assessed by routine multiplex PCR assay. Representative isolates were grouped in MLVA clusters to evaluate genomic diversity and subjected to MLST.
Results
At HUG, from 2000-2014, 12,543 patients were MRSAcolonized or infected (incl. >75% screening swabs; 530 BSI). 
Conclusion
A multifaceted prevention program and possible changes in biologic fitness of the ST228 SCCmecI clone helped to decrease endemic MRSA rates for the last 7 years.
